These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31920114)

  • 21. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease.
    Ala A; Aliu E; Schilsky ML
    Dig Dis Sci; 2015 May; 60(5):1433-9. PubMed ID: 25605552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worsening of Wilson disease following penicillamine therapy.
    Kalita J; Kumar V; Chandra S; Kumar B; Misra UK
    Eur Neurol; 2014; 71(3-4):126-31. PubMed ID: 24356057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of Wilson disease in Japan].
    Shimizu N
    Rinsho Shinkeigaku; 2019 Sep; 59(9):565-569. PubMed ID: 31474637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
    Harada M; Miyagawa K; Honma Y; Hiura M; Shibata M; Matsuhashi T; Abe S; Harada R; Tabaru A
    Intern Med; 2011; 50(14):1461-4. PubMed ID: 21757830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl.
    Mohr I; Bourhis H; Woimant F; Obadia MA; Morgil M; Morvan E; Merle U; Denk G; Poujois A; Weiss KH
    J Gastroenterol Hepatol; 2023 Feb; 38(2):219-224. PubMed ID: 36331262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological worsening in Wilson disease - clinical classification and outcome.
    Mohr I; Pfeiffenberger J; Eker E; Merle U; Poujois A; Ala A; Weiss KH
    J Hepatol; 2023 Aug; 79(2):321-328. PubMed ID: 37116715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King's College Hospital and review of the literature.
    Taylor RM; Chen Y; Dhawan A;
    Eur J Pediatr; 2009 Sep; 168(9):1061-8. PubMed ID: 19066958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wilson's disease.
    Walshe JM
    Lancet; 2007 Mar; 369(9565):902. PubMed ID: 17368141
    [No Abstract]   [Full Text] [Related]  

  • 34. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc?
    Ranucci G; Di Dato F; Leone F; Vajro P; Spagnuolo MI; Iorio R
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):e72-e73. PubMed ID: 25341025
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit.
    Kumar S; Patra BR; Irtaza M; Rao PK; Giri S; Darak H; Gopan A; Kale A; Shukla A
    Clin Drug Investig; 2022 Feb; 42(2):177-184. PubMed ID: 35102516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
    Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of Wilson's disease.
    Subramanian I; Vanek ZF; Bronstein JM
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.